A detailed history of Mastrapasqua Asset Management Inc transactions in Novartis Ag stock. As of the latest transaction made, Mastrapasqua Asset Management Inc holds 3,275 shares of NVS stock, worth $324,487. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,275
Previous 3,175 3.15%
Holding current value
$324,487
Previous $320,000 4.06%
% of portfolio
0.04%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 25, 2023

BUY
$94.73 - $105.13 $9,473 - $10,513
100 Added 3.15%
3,275 $333,000
Q2 2023

Aug 02, 2023

SELL
$92.52 - $104.91 $2,775 - $3,147
-30 Reduced 0.94%
3,175 $320,000
Q1 2023

Apr 27, 2023

BUY
$80.03 - $92.81 $65,624 - $76,104
820 Added 34.38%
3,205 $294,000
Q4 2022

Feb 01, 2023

BUY
$75.55 - $92.52 $180,186 - $220,660
2,385 New
2,385 $216,000
Q1 2021

May 03, 2021

SELL
$83.5 - $98.47 $481,795 - $568,171
-5,770 Closed
0 $0
Q4 2020

Feb 02, 2021

SELL
$78.07 - $94.43 $4.94 Million - $5.98 Million
-63,340 Reduced 91.65%
5,770 $545,000
Q3 2020

Nov 12, 2020

BUY
$82.14 - $91.0 $182,432 - $202,111
2,221 Added 3.32%
69,110 $6.01 Million
Q2 2020

Jul 29, 2020

BUY
$80.93 - $91.1 $61,425 - $69,144
759 Added 1.15%
66,889 $5.84 Million
Q1 2020

May 08, 2020

BUY
$70.67 - $99.01 $302,820 - $424,257
4,285 Added 6.93%
66,130 $5.45 Million
Q4 2019

Feb 05, 2020

BUY
$84.35 - $95.37 $150,564 - $170,235
1,785 Added 2.97%
61,845 $5.86 Million
Q3 2019

Nov 12, 2019

BUY
$85.54 - $94.26 $4.6 Million - $5.07 Million
53,785 Added 857.13%
60,060 $5.22 Million
Q2 2019

Aug 12, 2019

BUY
$75.4 - $92.8 $85,202 - $104,864
1,130 Added 21.96%
6,275 $573,000
Q1 2019

May 14, 2019

BUY
$75.32 - $86.15 $387,521 - $443,241
5,145 New
5,145 $495,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $213B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Mastrapasqua Asset Management Inc Portfolio

Follow Mastrapasqua Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mastrapasqua Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mastrapasqua Asset Management Inc with notifications on news.